Skip to main content

Table 3 Hazard of unfavorable treatment outcome at the end of follow-up among those active in HAART care at months 6, 12, 18 and 24 months

From: Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia

Variable Sub-category Hazard ratio, adj P-value
Ever discontinued HAART before 6 months No 1  
Yes 1.9 0.003
Ever discontinued HAART before 12 months No 1  
Yes 2.4 <0.001
Ever discontinued HAART before 18 months No 1  
Yes 2.6 <0.001
Ever discontinued ART before 24 months No 1  
Yes 2.4 <0.001